The addition of durvalumab and bevacizumab to TACE significantly improved progression-free survival in patients with…
Patients with metastatic castration-resistant prostate cancer (mCRPC) with extrapelvic nodal or visceral metastasis who were…
The American Society of Clinical Oncology (ASCO) has issued updated guidelines for geriatric oncology, outlining…
Researchers from Edith Cowan University (ECU) are leading ground-breaking global trials which could save lives…
A targeted drug combination for patients with a type of ovarian cancer could be nearly twice as…
Updated dose expansion data of the phase I STRO-002-GM1 study were presented today by Ana Oaknin, Principal…
Ciltacabtagene autoleucel, a BCMA-targeting CAR T-cell therapy, significantly slows or stops progression of multiple myeloma…
Patients with early relapsed or refractory large B-cell lymphoma had significantly improved overall survival when treated with the chimeric…
Results from the largest prospective study of primary mediastinal B-cell lymphoma show that radiation therapy…
The SYMPLIFY study is the first large-scale evaluation of a multi-cancer early detection (MCED) test in individuals…